Skip to content

A multicentre, randomised, double blind, placebo-controlled, parallel group trial of the effectiveness of the nocturnal use of a Temperature Controlled Laminar Airflow (TLA) device (Protexo®) in adults with poorly-controlled, severe allergic asthma: the LASER trial

Project: Research

Description

Funded by the NIHR Health Technology Assessment programme
StatusActive
Effective start/end date1/07/14 → …

Collaborative partners

Relations

ID: 2559232